Moderna Competitors and Similar CompaniesClear all
Moderna's competitors and similar companies include Celyad.
 Moderna Moderna (formerly Moderna Therapeutics) is a biotechnology company focused on messenger RNA (mRNA) medicine. |  Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology. | |
Founding Date | Founding Date 2010 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Mont-Saint-Guibert, BE HQ New York, US | |
Employees | Employees 5,60044% increase | Employees 17 |
Valuation ($) | Valuation ($) 21.2 b | Valuation ($) 11.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $3.2b (FY, 2024) | Revenue (est.) €102k (FY, 2023) |
Cost of goods | Cost of goods $1.5b (FY, 2024) | Cost of goods €69k (FY, 2023) |
Gross profit | Gross profit $1.8b (FY, 2024) | Gross profit €1.4m (FY, 2023) |
Net income | Net income ($3.6b) (FY, 2024) | Net income (€8.4m) (FY, 2023) |
For sources of this data, please see the company profile
View Company Profiles
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
17
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
View company